Convergent synaptic and circuit substrates underlying autism genetic risks

Frontiers in Biology

Volumn 9, Issue 2, 2014, Pages 137-150

  McGee, Aaron ^a   Li, Guohui ^b   Lu, Zhongming ^c   Qiu, Shenfeng ^b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

autism spectrum disorders; behavior; circuits; development; neurodevelopmental disorders; risk genes; synapse

Indexed keywords

EID: 84897475635     PISSN: 16747984     EISSN: 16747992     Source Type: Journal    
DOI: 10.1007/s11515-014-1298-y     Document Type: Review

References (136)

1. Abrahams B S, Geschwind D H (2008). Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet, 9(5): 341-355.
2. Alarcón M, Abrahams B S, Stone J L, Duvall J A, Perederiy J V, Bomar J M, Sebat J, Wigler M, Martin C L, Ledbetter D H, Nelson S F, Cantor RM, Geschwind D H (2008). Linkage, association, and geneexpression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet, 82(1): 150-159.
3. Amir R E, van den Veyver I B, Wan M, Tran C Q, Francke U, Zoghbi H Y (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 23(2): 185-188.
4. Arking D E, Cutler D J, Brune C W, Teslovich T M, West K, Ikeda M, Rea A, Guy M, Lin S, Cook E H Jr, Chakravarti A (2008). A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet, 82(1): 160-164.
5. Asaka Y, Jugloff D G, Zhang L, Eubanks J H, Fitzsimonds R M (2006). Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis, 21(1): 217-227.
6. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med, 25(1): 63-77.
7. Baker J P (2013). Autism at 70-redrawing the boundaries. N Engl J Med, 369(12): 1089-1091.
8. Baker P, Piven J, Sato Y (1998). Autism and tuberous sclerosis complex: prevalence and clinical features. J Autism Dev Disord, 28(4): 279-285.
9. Banerjee-Basu S, Packer A (2010). SFARI gene: an evolving database for the autism research community. Dis Model Mech, 3(3-4): 133-135.
10. Bateup H S, Johnson C A, Denefrio C L, Saulnier J L, Kornacker K, Sabatini B L (2013). Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron, 78(3): 510-522.
11. Bateup H S, Takasaki K T, Saulnier J L, Denefrio C L, Sabatini B L (2011). Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J Neurosci, 31(24): 8862-8869.
12. Belichenko P V, Oldfors A, Hagberg B, Dahlström A (1994). Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport, 5(12): 1509-1513.
13. Belmonte M K, Bourgeron T (2006). Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci, 9(10): 1221-1225.
14. Bonaglia M C, Giorda R, Mani E, Aceti G, Anderlid B M, Baroncini A, Pramparo T, Zuffardi O (2006). Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13. 3 deletion syndrome. J Med Genet, 43(10): 822-828.
15. Bostrom C A, Majaess NM, Morch K, White E, Eadie B D, Christie B R (2013) Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice. Cereb Cortex, doi: 10. 1093/cencor/bht237.
16. Bourgeron T (2009). A synaptic trek to autism. Curr Opin Neurobiol, 19(2): 231-234.
17. Bureau I, Shepherd G M, Svoboda K (2008). Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. J Neurosci, 28(20): 5178-5188.
18. Casanova M F, Buxhoeveden D, Switala A, Roy E (2003). Rett syndrome as a minicolumnopathy. Clin Neuropathol, 22(4): 163-168.
19. Casanova M F, Buxhoeveden D P, Switala A E, Roy E (2002). Minicolumnar pathology in autism. Neurology, 58(3): 428-432.
20. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A (2010). A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol, 20(2): 451-458.
21. Chahrour M, Zoghbi H Y (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron, 56(3): 422-437.
22. Chao H T, Chen H, Samaco R C, Xue M, Chahrour M, Yoo J, Neul J L, Gong S, Lu H C, Heintz N, Ekker M, Rubenstein J L, Noebels J L, Rosenmund C, Zoghbi H Y (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature, 468(7321): 263-269.
23. Chen H J, Rojas-Soto M, Oguni A, Kennedy M B (1998). A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron, 20(5): 895-904.
24. Clement J P, Aceti M, Creson T K, Ozkan E D, Shi Y, Reish N J, Almonte A G, Miller B H, Wiltgen B J, Miller C A, Xu X, Rumbaugh G (2012). Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell, 151(4): 709-723.
25. Clowry G, Molnár Z, Rakic P (2010). Renewed focus on the developing human neocortex. J Anat, 217(4): 276-288.
26. Comery T A, Harris J B, Willems P J, Oostra B A, Irwin S A, Weiler I J, Greenough W T (1997). Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA, 94(10): 5401-5404.
27. Cook E H Jr, Courchesne R Y, Cox N J, Lord C, Gonen D, Guter S J, Lincoln A, Nix K, Haas R, Leventhal B L, Courchesne E (1998). Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet, 62(5): 1077-1083.
28. Courchesne E, Pierce K (2005). Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol, 15(2): 225-230.
29. Crino P B, Nathanson K L, Henske E P (2006). The tuberous sclerosis complex. N Engl J Med, 355(13): 1345-1356.
30. Cruz-Martín A, Crespo M, Portera-Cailliau C (2010). Delayed stabilization of dendritic spines in fragile X mice. J Neurosci, 30(23): 7793-7803.
31. Curatolo P, Bombardieri R, Jozwiak S (2008). Tuberous sclerosis. Lancet, 372(9639): 657-668.
32. Curia G, Papouin T, Séguéla P, Avoli M (2009). Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb Cortex, 19(7): 1515-1520.
33. Dölen G, Osterweil E, Rao B S, Smith G B, Auerbach B D, Chattarji S, Bear M F (2007). Correction of fragile X syndrome in mice. Neuron, 56(6): 955-962.
34. Durand C M, Betancur C, Boeckers T M, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg I C, Anckarsäter H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni M C, de Mas P, Bieth E, Rogé B, Héron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet, 39(1): 25-27.
35. Durand C M, Perroy J, Loll F, Perrais D, Fagni L, Bourgeron T, Montcouquiol M, Sans N (2011). SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry, 17(1): 71-84.
36. +/- mouse model of tuberous sclerosis. Nat Med, 14(8): 843-848.
37. Eigsti I M, Shapiro T (2003). A systems neuroscience approach to autism: biological, cognitive, and clinical perspectives. Ment Retard Dev Disabil Res Rev, 9(3): 205-215.
38. Fombonne E, Rogé B, Claverie J, Courty S, Frémolle J (1999). Microcephaly and macrocephaly in autism. J Autism Dev Disord, 29(2): 113-119.
39. Gauthier J, Spiegelman D, Piton A, Lafrenière R G, Laurent S, St-Onge J, Lapointe L, Hamdan F F, Cossette P, Mottron L, Fombonne E, Joober R, Marineau C, Drapeau P, Rouleau G A (2009). Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet, 150B(3): 421-424.
40. Geschwind D H, Levitt P (2007). Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol, 17(1): 103-111.
41. Giacometti E, Luikenhuis S, Beard C, Jaenisch R (2007). Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA, 104(6): 1931-1936.
42. Gibson J R, Bartley A F, Hays S A, Huber K M (2008). Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol, 100(5): 2615-2626.
43. Gonçalves J T, Anstey J E, Golshani P, Portera-Cailliau C (2013). Circuit level defects in the developing neocortex of Fragile X mice. Nat Neurosci, 16(7): 903-909.
44. +/- mice in the absence of cerebral lesions and seizures. Ann Neurol, 62(6): 648-655.
45. Greer P L, Hanayama R, Bloodgood B L, Mardinly A R, Lipton D M, Flavell SW, Kim T K, Griffith E C, Waldon Z, Maehr R, Ploegh H L, Chowdhury S, Worley P F, Steen J, Greenberg M E (2010). The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell, 140(5): 704-716.
46. Guy J, Hendrich B, Holmes M, Martin J E, Bird A (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet, 27(3): 322-326.
47. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen L A, Ozonoff S, Lajonchere C, Grether J K, Risch N (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry, 68(11): 1095-1102.
48. Hamdan F F, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs M O, Joober R, Lacaille J C, Nadeau A, Milunsky J M, Wang Z, Carmant L, Mottron L, Beauchamp M H, Rouleau G A, Michaud J L (2011). De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry, 69(9): 898-901.
49. Hamdan F F, Gauthier J, Spiegelman D, Noreau A, Yang Y, Pellerin S, Dobrzeniecka S, Côté M, Perreau-Linck E, Carmant L, D'Anjou G, Fombonne E, Addington A M, Rapoport J L, Delisi L E, Krebs M O, Mouaffak F, Joober R, Mottron L, Drapeau P, Marineau C, Lafrenière R G, Lacaille J C, Rouleau G A, Michaud J L, and the Synapse to Disease Group (2009). Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med, 360(6): 599-605.
50. Hayashi M K, Tang C, Verpelli C, Narayanan R, Stearns M H, Xu R M, Li H, Sala C, Hayashi Y (2009). The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell, 137(1): 159-171.
51. Hong S, Ke X, Tang T, Hang Y, Chu K, Huang H, Ruan Z, Lu Z, Tao G, Liu Y (2011). Detecting abnormalities of corpus callosum connectivity in autism using magnetic resonance imaging and diffusion tensor tractography. Psychiatry Res, 194(3): 333-339.
52. Hsiao E Y (2013). Immune dysregulation in autism spectrum disorder. Int Rev Neurobiol, 113: 269-302.
53. Hsiao E Y, McBride S W, Hsien S, Sharon G, Hyde E R, McCue T, Codelli J A, Chow J, Reisman S E, Petrosino J F, Patterson P H, Mazmanian S K (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell, 155(7): 1451-1463.
54. Huber K M, Gallagher S M, Warren S T, Bear M F (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA, 99(11): 7746-7750.
55. Hutsler J J, Zhang H (2010). Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res, 1309: 83-94.
56. Irwin S A, Galvez R, Greenough W T (2000). Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex, 10(10): 1038-1044.
57. Irwin S A, Patel B, Idupulapati M, Harris J B, Crisostomo R A, Larsen B P, Kooy F, Willems P J, Cras P, Kozlowski P B, Swain R A, Weiler I J, Greenough W T (2001). Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet, 98(2): 161-167.
58. Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg I C, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T, Gillberg C, Råstam M, Gillberg C, Nydén A, Söderström H, Leboyer M, Betancur C, Philippe A, Giros B, Colineaux C, Cohen D, Chabane N, Mouren-Siméoni M C, Brice A, Sponheim E, Spurkland I, Skjeldal O H, Coleman M, Pearl P L, Cohen I L, Tsiouris J, Zappella M, Menchetti G, Pompella A, Aschauer H, van Maldergem L, and the Paris Autism Research International Sibpair Study (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet, 34(1): 27-29.
59. Jiang Y, Tsai T F, Bressler J, Beaudet A L (1998a). Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev, 8(3): 334-342.
60. Jiang Y H, Armstrong D, Albrecht U, Atkins C M, Noebels J L, Eichele G, Sweatt J D, Beaudet A L (1998b). Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron, 21(4): 799-811.
61. Just M A, Cherkassky V L, Keller T A, Kana R K, Minshew N J (2007). Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex, 17(4): 951-961.
62. Just M A, Cherkassky V L, Keller T A, Minshew N J (2004). Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain, 127(Pt 8): 1811-1821.
63. Kana R K, Keller T A, Cherkassky V L, Minshew N J, Just M A (2009). Atypical frontal-posterior synchronization of Theory of Mind regions in autism during mental state attribution. Soc Neurosci, 4(2): 135-152.
64. Kanner L (1943) Autistic disturbances of affective contact. Nervous Child, 2: 217-250.
65. Kattenstroth G, Tantalaki E, Südhof T C, Gottmann K, Missler M (2004). Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. Proc Natl Acad Sci USA, 101(8): 2607-2612.
66. Kelleher R J 3rd, Bear M F (2008). The autistic neuron: troubled translation? Cell, 135(3): 401-406.
67. Kim H G, Kishikawa S, Higgins AW, Seong I S, Donovan D J, Shen Y, Lally E, Weiss L A, Najm J, Kutsche K, Descartes M, Holt L, Braddock S, Troxell R, Kaplan L, Volkmar F, Klin A, Tsatsanis K, Harris D J, Noens I, Pauls D L, Daly MJ, MacDonald ME, Morton C C, Quade B J, Gusella J F (2008). Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet, 82(1): 199-207.
68. Kim J H, Liao D, Lau L F, Huganir R L (1998). SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron, 20(4): 683-691.
69. Kishino T, Lalande M, Wagstaff J (1997). UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet, 15(1): 70-73.
70. Komiyama N H, Watabe A M, Carlisle H J, Porter K, Charlesworth P, Monti J, Strathdee D J, O'Carroll C M, Martin S J, Morris R G, O'Dell T J, Grant S G (2002). SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci, 22(22): 9721-9732.
71. Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham D E (2004). SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron, 43(4): 563-574.
72. Lainhart J E (2003). Increased rate of head growth during infancy in autism. JAMA, 290(3): 393-394.
73. Landa R J, Holman K C, Garrett-Mayer E (2007). Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch Gen Psychiatry, 64(7): 853-864.
74. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, Raynaud M, Ronce N, Lemonnier E, Calvas P, Laudier B, Chelly J, Fryns J P, Ropers H H, Hamel B C, Andres C, Barthélémy C, Moraine C, Briault S (2004). X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet, 74(3): 552-557.
75. Leung A K, Robson W L (2007). Tuberous sclerosis complex: a review. J Pediatr Health Care, 21(2): 108-114.
76. Li J, Pelletier M R, Perez Velazquez J L, Carlen P L (2002). Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci, 19(2): 138-151.
77. Ma A, Wang L, Gao Y, Chang Z, Peng H, Zeng N, Gui Y S, Tian X, Li X, Cai B, Zhang H, Xu K F (2014). Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality. Hum Mol Genet, 23(3): 693-705.
78. Matsuura T, Sutcliffe J S, Fang P, Galjaard R J, Jiang Y H, Benton C S, Rommens JM, Beaudet A L (1997). De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet, 15(1): 74-77.
79. McGraw C M, Samaco R C, Zoghbi H Y (2011). Adult neural function requires MeCP2. Science, 333(6039): 186.
80. McMahon A C, Barnett M W, O'Leary T S, Stoney P N, Collins M O, Papadia S, Choudhary J S, Komiyama N H, Grant S G, Hardingham G E, Wyllie D J, Kind P C (2012). SynGAP isoforms exert opposing effects on synaptic strength. Nat Commun, 3: 900.
81. Meyer G, Varoqueaux F, Neeb A, Oschlies M, Brose N (2004). The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology, 47(5): 724-733.
82. Miles J H (2011). Autism spectrum disorders-a genetics review. Genet Med, 13(4): 278-294.
83. Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt J D, Zoghbi H Y (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci, 26(1): 319-327.
84. Moy S S, Nadler J J (2008). Advances in behavioral genetics: mouse models of autism. Mol Psychiatry, 13(1): 4-26.
85. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K, Tomonaga S, Watanabe Y, Chung Y J, Banerjee R, Iwamoto K, Kato T, Okazawa M, Yamauchi K, Tanda K, Takao K, Miyakawa T, Bradley A, Takumi T (2009). Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell, 137(7): 1235-1246.
86. Nestler E J, Hyman S E (2010). Animal models of neuropsychiatric disorders. Nat Neurosci, 13(10): 1161-1169.
87. Neul J L, Fang P, Barrish J, Lane J, Caeg E B, Smith E O, Zoghbi H, Percy A, Glaze D G (2008). Specific mutations in methyl-CpGbinding protein 2 confer different severity in Rett syndrome. Neurology, 70(16): 1313-1321.
88. Okamoto N, Kubota T, Nakamura Y, Murakami R, Nishikubo T, Tanaka I, Takahashi Y, Hayashi S, Imoto I, Inazawa J, Hosokai N, Kohsaka S, Uchino S (2007). 22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome? Am J Med Genet A, 143A(23): 2804-2809.
89. Olmos-Serrano J L, Paluszkiewicz S M, Martin B S, Kaufmann W E, Corbin J G, Huntsman M M (2010). Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci, 30(29): 9929-9938.
90. Onda H, Lueck A, Marks P W, Warren H B, Kwiatkowski D J (1999). Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest, 104(6): 687-695.
91. Osterweil E K, Chuang S C, Chubykin A A, Sidorov M, Bianchi R, Wong R K, Bear M F (2013). Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron, 77(2): 243-250.
92. Osterweil E K, Krueger D D, Reinhold K, Bear M F (2010). Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci, 30(46): 15616-15627.
93. Padmashri R, Reiner B C, Suresh A, Spartz E, Dunaevsky A (2013). Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome. J Neurosci, 33(50): 19715-19723.
94. Pan F, Aldridge GM, Greenough WT, Gan WB (2010). Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA, 107(41): 17768-17773.
95. Parker-Athill E C, Tan J (2010). Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals, 18(2): 113-128.
96. Peça J, Feliciano C, Ting J T, Wang W, Wells M F, Venkatraman T N, Lascola C D, Fu Z, Feng G (2011). Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature, 472(7344): 437-442.
97. Peñagarikano O, Abrahams B S, Herman E I, Winden K D, Gdalyahu A, Dong H, Sonnenblick L I, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg J T, Peles E, Geschwind D H (2011). Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell, 147(1): 235-246.
98. Pfeiffer B E, Huber K M (2007). Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. J Neurosci, 27(12): 3120-3130.
99. Pierre G (2013). Neurodegenerative disorders and metabolic disease. Arch Dis Child, 98(8): 618-624.
100. Piggot J, Shirinyan D, Shemmassian S, Vazirian S, Alarcón M (2009). Neural systems approaches to the neurogenetics of autism spectrum disorders. Neuroscience, 164(1): 247-256.
101. Pinto D, Pagnamenta A T, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes T R, Correia C, Abrahams B S, Almeida J, Bacchelli E, Bader G D, Bailey A J, Baird G, Battaglia A, Berney T, Bolshakova N, Bölte S, Bolton P F, Bourgeron T, Brennan S, Brian J, Bryson S E, Carson A R, Casallo G, Casey J, Chung B H, Cochrane L, Corsello C, Crawford E L, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez B A, Folstein S E, Fombonne E, Freitag C M, Gilbert J, Gillberg C, Glessner J T, Goldberg J, Green A, Green J, Guter S J, Hakonarson H, Heron E A, Hill M, Holt R, Howe J L, Hughes G, Hus V, Igliozzi R, Kim C, Klauck S M, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere C M, Lamb J A, Laskawiec M, Leboyer M, Le Couteur A, Leventhal B L, Lionel A C, Liu X Q, Lord C, Lotspeich L, Lund S C, Maestrini E, Mahoney W, Mantoulan C, Marshall C R, McConachie H, McDougle C J, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew N J, Mirza G K, Munson J, Nelson S F, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr J R, Parrini B, Paton T, Pickles A, Pilorge M, Piven J, Ponting C P, Posey D J, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter M L, Bierut L J, Rice J P, Salt J, Sansom K, Sato D, Segurado R, Sequeira A F, Senman L, Shah N, Sheffield V C, Soorya L, Sousa I, Stein O, Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson A P, Thomson S, Tryfon A, Tsiantis J, van Engeland H, Vincent J B, Volkmar F, Wallace S, Wang K, Wang Z, Wassink T H, Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan B L, Zurawiecki D, Zwaigenbaum L, Buxbaum J D, Cantor R M, Cook E H, Coon H, Cuccaro M L, Devlin B, Ennis S, Gallagher L, Geschwind D H, Gill M, Haines J L, Hallmayer J, Miller J, Monaco A P, Nurnberger J I Jr, Paterson A D, Pericak-Vance M A, Schellenberg G D, Szatmari P, Vicente A M, Vieland V J, Wijsman E M, Scherer S W, Sutcliffe J S, Betancur C (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466(7304): 368-372.
102. Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer J L, Trimmer J S, Shrager P, Peles E (1999). Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron, 24(4): 1037-1047.
103. + channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol, 162(6): 1149-1160.
104. Qin M, Kang J, Burlin T V, Jiang C, Smith C B (2005). Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. J Neurosci, 25(20): 5087-5095.
105. Ricciardi S, Boggio E M, Grosso S, Lonetti G, Forlani G, Stefanelli G, Calcagno E, Morello N, Landsberger N, Biffo S, Pizzorusso T, Giustetto M, Broccoli V (2011). Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet, 20(6): 1182-1196.
106. Riday T T, Dankoski E C, Krouse M C, Fish E W, Walsh P L, Han J E, Hodge C W, Wightman R M, Philpot B D, Malanga C J (2012). Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest, 122(12): 4544-4554.
107. Rosenblueth A W N, Wiener N (1945). The role of models in science. Philos Sci, 12(4): 316-321.
108. Roussignol G, Ango F, Romorini S, Tu J C, Sala C, Worley P F, Bockaert J, Fagni L (2005). Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci, 25(14): 3560-3570.
109. Rubenstein J L (2010). Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol, 23(2): 118-123.
110. Rubenstein J L, Merzenich M M (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav, 2(5): 255-267.
111. Rumbaugh G, Adams J P, Kim J H, Huganir R L (2006). SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc Natl Acad Sci USA, 103(12): 4344-4351.
112. Sahyoun C P, Belliveau J W, Soulières I, Schwartz S, Mody M (2010). Neuroimaging of the functional and structural networks underlying visuospatial vs. linguistic reasoning in high-functioning autism. Neuropsychologia, 48(1): 86-95.
113. Scott-van Zeeland A A, Abrahams B S, Alvarez-Retuerto A I, Sonnenblick L I, Rudie J D, Ghahremani D, Mumford J A, Poldrack R A, Dapretto M, Geschwind D H, Bookheimer S Y (2010). Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med, 2(56): 56ra80.
114. Sheng M, Kim E (2000). The Shank family of scaffold proteins. J Cell Sci, 113(Pt 11): 1851-1856.
115. Shukla D K, Keehn B, Müller R A (2011a). Tract-specific analyses of diffusion tensor imaging show widespread white matter compromise in autism spectrum disorder. J Child Psychol Psychiatry, 52(3): 286-295.
116. Shukla D K, Keehn B, Smylie DM, Müller R A (2011b). Microstructural abnormalities of short-distance white matter tracts in autism spectrum disorder. Neuropsychologia, 49(5): 1378-1382.
117. Silverman J L, Yang M, Lord C, Crawley J N (2010). Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci, 11(7): 490-502.
118. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg I C, Jakobsson G, Bohman M(1989). A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry, 30(3): 405-416.
119. Strauss K A, Puffenberger E G, Huentelman MJ, Gottlieb S, Dobrin S E, Parod J M, Stephan D A, Morton D H (2006). Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med, 354(13): 1370-1377.
120. Südhof T C (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature, 455(7215): 903-911.
121. Tabuchi K, Blundell J, Etherton M R, Hammer R E, Liu X, Powell C M, Südhof T C (2007). A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science, 318(5847): 71-76.
122. Thomas C, Humphreys K, Jung K J, Minshew N, Behrmann M (2011). The anatomy of the callosal and visual-association pathways in highfunctioning autism: a DTI tractography study. Cortex, 47(7): 863-873.
123. Uhlmann E J, Wong M, Baldwin R L, Bajenaru M L, Onda H, Kwiatkowski D J, Yamada K, Gutmann D H (2002). Astrocytespecific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol, 52(3): 285-296.
124. van Woerden GM, Harris K D, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R, Jiang Y H, Elgersma Y, Weeber E J (2007). Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation. Nat Neurosci, 10(3): 280-282.
125. Varoqueaux F, Aramuni G, Rawson R L, Mohrmann R, Missler M, Gottmann K, Zhang W, Südhof T C, Brose N (2006). Neuroligins determine synapse maturation and function. Neuron, 51(6): 741-754.
126. Vernes S C, Newbury D F, Abrahams B S, Winchester L, Nicod J, Groszer M, Alarcón M, Oliver P L, Davies K E, Geschwind D H, Monaco A P, Fisher S E (2008). A functional genetic link between distinct developmental language disorders. N Engl J Med, 359(22): 2337-2345.
127. Wallace M L, Burette A C, Weinberg R J, Philpot B D (2012). Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron, 74(5): 793-800.
128. Walsh C A, Morrow E M, Rubenstein J L (2008). Autism and brain development. Cell, 135(3): 396-400.
129. Wang X, McCoy P A, Rodriguiz R M, Pan Y, Je H S, Roberts A C, Kim C J, Berrios J, Colvin J S, Bousquet-Moore D, Lorenzo I, Wu G, Weinberg R J, Ehlers M D, Philpot B D, Beaudet A L, Wetsel W C, Jiang Y H (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet, 20(15): 3093-3108.
130. Weeber E J, Jiang Y H, Elgersma Y, Varga A W, Carrasquillo Y, Brown S E, Christian J M, Mirnikjoo B, Silva A, Beaudet A L, Sweatt J D (2003). Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci, 23(7): 2634-2644.
131. Writzl K, Knegt A C (2013). 6p21. 3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment. Am J Med Genet A, 161A(7): 1682-1685.
132. Yashiro K, Riday T T, Condon K H, Roberts A C, Bernardo D R, Prakash R, Weinberg R J, Ehlers M D, Philpot B D (2009). Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci, 12(6): 777-783.
133. Zahir F R, Baross A, Delaney A D, Eydoux P, Fernandes N D, Pugh T, Marra MA, Friedman J M (2008). A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1α. J Med Genet, 45(4): 239-243.
134. Zhou Z, Hong E J, Cohen S, Zhao WN, Ho H Y, Schmidt L, Chen WG, Lin Y, Savner E, Griffith E C, Hu L, Steen J A, Weitz C J, Greenberg M E (2006). Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52(2): 255-269.
135. Zoghbi H Y (2003). Postnatal neurodevelopmental disorders: meeting at the synapse? Science, 302(5646): 826-830.
136. Zoghbi H Y, Bear M F (2012). Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol, 4(3): 4.